ShareHope Medicine Co Ltd (8403) — Cash Flow-to-Debt Ratio
ShareHope Medicine Co Ltd (8403) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of NT$113.37 Million could theoretically repay 0% of its total liabilities (NT$2.78 Billion) in one year. Check ShareHope Medicine Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ShareHope Medicine Co Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for ShareHope Medicine Co Ltd across 9 annual periods. Also explore balance sheet size of ShareHope Medicine Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year debt coverage analysis for ShareHope Medicine Co Ltd. For market capitalisation and broader financial context, see ShareHope Medicine Co Ltd (8403) total market value.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | NT$364.12 Million | NT$2.78 Billion | ▲ +53.1% |
| 2024 | 0.09x | NT$266.68 Million | NT$3.12 Billion | ▲ +16.0% |
| 2023 | 0.07x | NT$257.13 Million | NT$3.49 Billion | ▼ -62.4% |
| 2022 | 0.20x | NT$642.47 Million | NT$3.28 Billion | ▲ +21.3% |
| 2021 | 0.16x | NT$360.10 Million | NT$2.23 Billion | ▼ -52.6% |
| 2020 | 0.34x | NT$717.74 Million | NT$2.11 Billion | ▲ +2.6% |
| 2019 | 0.33x | NT$502.62 Million | NT$1.51 Billion | ▲ +1160.8% |
| 2018 | 0.03x | NT$33.91 Million | NT$1.29 Billion | ▼ -44.8% |
| 2017 | 0.05x | NT$62.76 Million | NT$1.31 Billion | — |